A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
To assess the multiple-dose pharmacokinetics (PK), safety and tolerability of AVP-786
(deuterated [d6] dextromethorphan hydrobromide [DM]/quinidine sulfate [Q]) in healthy
volunteers.